Neurab

Neurab is an Italian startup that has developed the Neurotablet, a neurocognitive rehabilitation device for patients with brain injury. Rather than doing manual exercises on paper, patients and caregivers are offered a personalised, digital exercise program combined with an easy-to-use tablet. MedScaler and Neurab partnered up in to perform an Initial Market Exploration in the Dutch healthcare market. While exploring the initial interest amongst hospitals, centers for rehabilitation care, centers for disabled care and centers for elderly care, we received a lot of positive responses. We are now continuing with the Market Integration module during which, together with experts and healthcare professionals, we will carefully map the implementation setting, buying decisions, stakeholder system and identify potential bottlenecks.

In order to give more insights about this inspiring innovation, MedScaler interviewed Beatrice Festini, PR & Communications Manager at Neurab.

How is your innovation revolutionising healthcare?

“Neurab developed a cognitive neurorehabilitation programme for people affected by acquired brain disorders (stroke, traumatic brain injuries, multiple sclerosis, dementia…). The Neurotablet is a software-hardware device created with two different interfaces: a therapist version, allowing therapists to create specific treatment plans for the patient’s specific needs, and a patient version, to allow them to autonomously perform their neurorehabilitation even at home (telemedicine). Therapists can remotely monitor patients’ progress and adjust/change the exercises and the treatment plan according to the patients’ performance.”